Results 201 to 210 of about 94,325 (274)

Early Low-Dose Rituximab for Mild-to-Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety. [PDF]

Int J Endocrinol
Lu M, Wang L, Zhang X.
europepmc   +1 more source

Processing of mitochondrial precursor proteins [PDF]

, 1984
Neupert, Walter, Schmidt, Bernd
core  

Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 95-104, March 2026.
ABSTRACT Vascular endothelial growth factor receptor 2 (VEGFR2) is a key target for anti‐angiogenic oncotherapy, as inhibiting this receptor on tumour vasculature slows tumour development and enhances drug‐ and immune infiltration, improving therapy outcome.
Esther Hindriks, Wilhelmina Bergmann, Aitor Martínez Ruiz, Maurice M. J. M. Zandvliet, Alice J. A. M. Sijts, Femke Broere   +5 more
wiley   +1 more source

Thyroid Eye Disease Following SARS-CoV-2 Vaccination: Experience of a Case Series. [PDF]

Vaccines (Basel)
Abreu Lomba A, Tello-Cajiao ME, Morales M, Martínez A, Salazar Moreno MA, Vernaza Trujillo DA, Gaibor-Pazmiño A, Izquierdo-Condoy JS.   +7 more
europepmc   +1 more source

Safety evaluation of blue galdieria extract as a food additive

EFSA Journal, Volume 24, Issue 3, March 2026.
Abstract The EFSA Panel on Food Additive and Flavourings (FAF Panel) provides a scientific opinion on the safety of blue galdieria extract as a food additive. Blue galdieria extract is an enzymatically treated C‐phycocyanin extract derived from the lysed biomass of the microalgae Galdieria sulphuraria.
EFSA Panel on Food Additives and Flavourings (FAF), Laurence Castle, Monica Andreassen, Gabriele Aquilina, Maria Lourdes Bastos, Polly Boon, Biagio Fallico, Reginald FitzGerald, Maria Jose Frutos Fernandez, Bettina Grasl‐Kraupp, Ursula Gundert‐Remy, Rainer Gürtler, Eric Houdeau, Marcin Kurek, Henriqueta Louro, Patricia Morales, Sabina Passamonti, José Manuel Barat Baviera, Gisela Degen, David Gott, Lieve Herman, Jean‐Charles Leblanc, Peter Moldeus, Ine Waalkens‐Berendsen, Detlef Wölfle, Civitella Consuelo, Ana Maria Rincon, Alexandra Tard, Alessandra Tosato, Panagiota Zakidou, Laura Ruggeri   +30 more
wiley   +1 more source

When Postoperative Inflammation Isn't Benign: Thyroid Eye Disease Following Cataract Surgery. [PDF]

Cureus
Chiew Y, Poh KW.
europepmc   +1 more source

Thyroid eye disease

, 2016
openaire   +1 more source

Global cancer statistics for children: Two decades of change and projections to 2050

CA: A Cancer Journal for Clinicians, Volume 76, Issue 2, March/April 2026.
Abstract Reliable, contemporary estimates of the global childhood cancer burden remain scarce, particularly in the post‐coronavirus disease 2019 (COVID‐19) era. By using data from the Global Burden of Disease 2021 and Global Cancer Observatory 2022 projects, the authors evaluated the childhood cancer burden at global, regional, and national levels ...
Wangzhong Li, Shanzhou Huang, Qiyue Chen, Ting Wang, Guanming Lu, Xing Niu, Qiong Song, Yilin Xu, Ke Mo, Chunhui Cui, Run Zhang, Wei Du, Feiying He, Lei Shi, Yan Lin, Qiu Wei, Li Jiang, Yongsheng Chen, Baiyang Song, Huijuan Zhang, Zhenli Fu, Wenjing Liao, Jiancong Sun, Wenhui Guan, Weitao Zhuang, Nanshan Zhong, Chengzhi Zhou, Wenhua Liang, Min Kang, Jianxing He   +29 more
wiley   +1 more source

Long-term Outcome After Correction of Lower Eyelid Retraction With Donor Sclera in Thyroid Eye Disease. [PDF]

Plast Reconstr Surg Glob Open
Halsøy K, Hope AM, Foshaug C, Lysebo DE, Rødahl E, Ueland HO.   +5 more
europepmc   +1 more source

Incidence and risk factors of tocilizumab-induced hypofibrinogenemia in patients with thyroid eye disease: a single-center retrospective study. [PDF]

Front Endocrinol (Lausanne)
Wang E, Hu Q, Xu S, Zhou J, Wang J, Song Z, Wang X.   +6 more
europepmc   +1 more source